Healthcare Sector Review: Winning and Losing Stocks on Dec 6th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Progenics Pharmaceuticals (NASDAQ:PGNX): The shares closed at $7.46, up $0.45, or 6.42%, on the day. Its market capitalization is $251.87 million. About the company: Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics’ principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology. Get the most recent company news and stock data here >>
  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $2.50, up $0.13, or 5.49%, on the day. Its market capitalization is $137.21 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies. Get the most recent company news and stock data here >>
  • AtriCure Inc. (NASDAQ:ATRC): The shares closed at $10.64, up $0.55, or 5.45%, on the day. Its market capitalization is $173.05 million. About the company: AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company’s bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation. Get the most recent company news and stock data here >>
  • Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $12.65, up $0.55, or 4.55%, on the day. Its market capitalization is $590.06 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance. Get the most recent company news and stock data here >>
  • ArQule, Inc. (NASDAQ:ARQL): The shares closed at $5.96, up $0.25, or 4.38%, on the day. Its market capitalization is $320.49 million. About the company: ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company’s platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule’s products are intended to be effective against multiple types of cancer. Get the most recent company news and stock data here >>

Losers (% price change)

  • Affymax, Inc. (NASDAQ:AFFY): The shares closed at $5.38, down $0.88, or 14.06%, on the day. Its market capitalization is $192.23 million. About the company: Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer. Get the most recent company news and stock data here >>
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $4.74, down $0.37, or 7.24%, on the day. Its market capitalization is $161.55 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals. Get the most recent company news and stock data here >>
  • Sangamo Biosciences, Inc. (NASDAQ:SGMO): The shares closed at $2.77, down $0.17, or 5.78%, on the day. Its market capitalization is $145.32 million. About the company: Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences. Get the most recent company news and stock data here >>
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $7.34, down $0.33, or 4.3%, on the day. Its market capitalization is $1.46 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes. Get the most recent company news and stock data here >>
  • BioScrip Inc. (NASDAQ:BIOS): The shares closed at $5.87, down $0.26, or 4.24%, on the day. Its market capitalization is $338.31 million. About the company: BioScrip, Inc. is a pharmacy benefit management and specialty pharmaceutical organization that partners with managed care organizations and healthcare providers to control prescription drug costs. The Company provides pharmacy benefit products and services and mail order pharmacy services, and is the fulfillment center for online retailers offering prescription and OTC products. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>